Member News
M3D Inc Awarded NSF SBIR Phase I Grant for Advanced Gamma Camera Design
M3D Inc. has secured a $275,000 SBIR Phase I award from the National Science Foundation (NSF) to advance its research on gamma camera designs aimed at improving sentinel lymph node biopsies, particularly in tough-to-navigate head and neck cancer cases. Surgeons often face a challenge when a lymph node is too close to the tumor. Radiotracers…
Read MoreONL Therapeutics Closes $65 Million in Oversubscribed Series D Financing
ANN ARBOR, Mich., September 13, 2024 – ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today announced that it has secured $65M in Series D financing. Johnson & Johnson Innovation – JJDC, Inc. led the round that was backed by a consortium of investors that included…
Read MoreTransPharm Preclinical Solutions: Pioneering Infectious Disease Research from Jackson, MI, with a Global Reach – MichBio Member Feature
On January 22nd, 2007, Pfizer Global Research and Development in Ann Arbor closed its doors, resulting in thousands of job losses. Just two days later, Dan Ross established TransPharm Preclinical Solutions. Ross’s motivations for starting the company were numerous, with the loss of his beloved job being a significant factor. Determined to continue working in…
Read MoreNew One-Day Surface Metrology and Tribology Class, November 14, 2024
LIVONIA, MI (July 7, 2024) – Registration is now open for the new one-day Surface Metrology and Tribology class which will be held in Livonia, Michigan, Nov. 14, 2024. The 1-day class offers a unique opportunity to learn the fundamentals of surface roughness, friction, and wear analysis, and their applications in manufacturing and product development.…
Read MoreNew TrialAssure LINK® AI 2.0 Medical Writing Technology Debuts to the Pharmaceutical Industry at the DIA Annual Conference in San Diego
SAN DIEGO (June 17, 2024) – TrialAssure, a leading provider of pharmaceutical technology advancing clinical trial disclosure, data sharing, and transparency, announced today the release of TrialAssure LINK® AI 2.0. This new version is updated and designed to assist pharmaceutical, biotechnology companies, clinical research organizations, and other service providers in creating drafts of common regulatory…
Read MoreCayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com
ANN ARBOR, MI, JUNE 5, 2024—Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com. PCRassays.com offers more than 200 qPCR-based assays for infectious diseases, over 50 of which are multiplex assays, including panels for wound, upper respiratory, urinary tract,…
Read MoreStryker to Acquire Artelon, Expanding Soft Tissue Fixation Solutions
Stryker (NYSE: SYK), a global medical technology leader, has signed an agreement to acquire Artelon, a company specializing in soft tissue fixation products for foot and ankle and sports medicine procedures. This acquisition aims to bolster Stryker’s capabilities in ligament and tendon reconstruction. Artelon’s synthetic technology enhances biological and mechanical reconstruction, with over 60,000 implantations…
Read MoreTrialAssure Launches Anonymize 3.0 Technology for an Improved Data and Document Anonymization User Experience in Pharma and Beyond
TrialAssure, a leading pharmaceutical technology provider advancing clinical trial disclosure, data sharing, and transparency, announced that its flagship product TrialAssure ANONYMIZE® 3.0 is now available. ANONYMIZE allows users across the pharmaceutical industry the ability to perform data, document, and image anonymization and redaction using machine learning (ML), natural language processing (NLP), and artificial intelligence (AI)…
Read More90,000 sq. ft. Expansion of Grand River Aseptic Manufacturing’s Finishing and Warehouse Center is Complete
Grand River Aseptic Manufacturing (“GRAM”), a leading sterile injectable contract manufacturer of biologics, small molecules, and vaccines, announces the completion of its finishing and warehouse center expansion. The expansion added 90,000 sq. ft. to the existing 110,000 sq. ft., totaling 200,000 sq. ft. of sophisticated inspection, packaging, testing, and warehouse capabilities. Grand River Aseptic Manufacturing…
Read MoreCayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies
ANN ARBOR, MI, FEBRUARY 22, 2024 – Cayman Chemical, a leading supplier of research tools for lipid nanoparticles (LNPs), announced today the introduction of LipidLaunch™ research-ready LNPs and reagent kits. The LipidLaunch™ product line is the latest addition to the company’s portfolio of LNP research tools and reflects the company’s legacy of providing high-quality lipids…
Read More